P&G officer plans sale of 359 shares under Rule 144

Rhea-AI Filing Summary

Procter & Gamble Co. (PG) received a Rule 144 notice from officer Matthew W. Janzaruk covering a proposed sale of up to 359 shares of common stock through Morgan Stanley Smith Barney LLC, with an estimated aggregate market value of $51,602.66 based on pricing as of August 20, 2026. The securities to be sold are tied to a Performance Stock Program Award dated August 19, 2026 for 515 shares. Janzaruk previously sold 156 shares of Procter & Gamble common stock during the past three months for an aggregate of $22,431.24. The notice is dated August 21, 2026.

Key Figures

Shares proposed to be sold: 359 shares Aggregate market value of proposed sale: $51,602.66 Performance Stock Program Award shares: 515 shares +4 more

7 metrics

Shares proposed to be sold 359 shares Common stock under Rule 144 notice

Aggregate market value of proposed sale $51,602.66 Estimated value of 359 shares of common stock

Performance Stock Program Award shares 515 shares Award from The Procter & Gamble Company dated August 19, 2026

Shares sold in past 3 months 156 shares Common stock sold on August 20, 2026

Aggregate amount from past 3-month sales $22,431.24 Sale of 156 shares on August 20, 2026

Proposed sale date 08/24/2026 Date associated with proposed sale of 359 shares

Notice date 08/21/2026 Date of Rule 144 notice signed on behalf of Matthew W. Janzaruk

Key Terms

Rule 144, Performance Stock Program Award, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Stock Program Award financial

"Common Stock | 08/19/2026 | Performance Stock Program Award |"

attorney-in-fact regulatory

"Signature | /s/ Wednesday Shipp, attorney-in-fact for Matthew W. Janzaruk"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 notice involving PG disclose about potential share sales?

The notice discloses that officer Matthew W. Janzaruk may sell up to 359 shares of Procter & Gamble common stock under Rule 144, with an estimated aggregate market value of $51,602.66, through Morgan Stanley Smith Barney LLC on or after August 24, 2026.

How many PG shares has Matthew W. Janzaruk sold recently?

During the past three months, Matthew W. Janzaruk sold 156 shares of Procter & Gamble common stock on August 20, 2026 for an aggregate amount of $22,431.24, based on the average of the high and low price that day.

What award is related to the securities in the PG Form 144 notice?

The securities referenced in the notice relate to a Performance Stock Program Award from The Procter & Gamble Company dated August 19, 2026 for 515 shares of common stock.

Who is the broker involved in the potential PG stock sale?

The proposed sale of up to 359 shares of Procter & Gamble common stock is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY.

When is the proposed sale date for the PG shares under this Form 144?

The notice lists a proposed sale date of August 24, 2026 for the potential sale of up to 359 shares of Procter & Gamble common stock under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/21/2026 - 02:43 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001910008
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PROCTER & GAMBLE Co
SEC File Number	001-00434
Address of Issuer	ONE PROCTER & GAMBLE PLAZA CINCINNATI OHIO 45202
Phone	5139831100
Name of Person for Whose Account the Securities are To Be Sold	Janzaruk Matthew W.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	359	51602.66	2324433060	08/24/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/19/2026	Performance Stock Program Award	The Procter & Gamble Company			515	08/19/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Matthew W. Janzaruk 1 Procter & Gamble Plaza Cincinnati OH 45202	Common Stock	08/20/2026	156	22431.24

144: Remarks and Signature

Remarks	1) Based on average of high and low price on August 20, 2026.
Date of Notice	08/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Wednesday Shipp, attorney-in-fact for Matthew W. Janzaruk
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)